Myasthenia Gravis
📧 Sign up to get email alerts when something new happens for Myasthenia Gravis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
A worldwide pregnancy safety study is recruiting to assess maternal, fetal, and infant outcomes after exposure to efgartigimod during pregna…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
This update outlines a non-interventional, post-authorization safety study of patients treated with efgartigimod alfa for myasthenia gravis,…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases [EARLY_Phase 1]
This document reports an early-phase (Phase 1) clinical trial of QT-019C UCAR T-cell therapy targeting CD19 and BCMA in relapsed/refractory …
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis [Phase 1, Phase 2]
A Phase 1b/2 trial of IM-101 in adults with generalized and ocular myasthenia gravis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
A long-term follow-up study for participants previously treated with KYV-101; recruitment is ongoing across multiple autoimmune diseases.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2) [Phase 1]
A Phase 1 study evaluating CC-97540 in relapsing and progressive forms of multiple sclerosis and refractory myasthenia gravis is currently r…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases [EARLY_Phase 1]
Early-phase clinical study of a targeted CD19/BCMA CAR-T therapy for autoimmune diseases is recruiting, including systemic lupus erythematos…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Detecting Fatigue From Voice in Generalised Myasthenia Gravis
Thymia Limited is conducting a clinical trial to detect fatigue from voice in generalized myasthenia gravis; the study status is NOT_YET_REC…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Ripertamab for the Treatment of Myasthenia Gravis [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial update for Ripertamab in Myasthenia Gravis. The study is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases [EARLY_Phase 1]
An early-phase UCAR-T therapy targeting CD19/BCMA is being evaluated for relapsing or refractory multiple sclerosis, myasthenia gravis, CIDP…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Proteomic Changes in Patients With Myasthenia Gravis and Ravulizumab
An update on a clinical trial studying proteomic changes in patients with Myasthenia Gravis treated with Ravulizumab, currently not recruiti…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases [EARLY_Phase 1]
A Phase 1 trial evaluating a universal CAR T-cell therapy targeting CD19 and BCMA in relapsed/refractory neurological autoimmune diseases, w…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Effectiveness and Safety of Zilucoplan Treatment for French Patients With Myasthenia Gravis Over 3 Months
A clinical trial updating on the effectiveness and safety of zilucoplan for French patients with myasthenia gravis over a three-month period…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: The EXPLORE MG Registry for Myasthenia Gravis
The EXPLORE MG Registry for Myasthenia Gravis at Yale University is currently recruiting participants to collect observational data on patie…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Evaluating Dyspnea in Autoimmune Myasthenia Gravis "Why am I Short of Breath?"
A clinical trial update outlines a planned study evaluating dyspnea in autoimmune myasthenia gravis. The trial is currently NOT_YET_RECRUITI…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis [EARLY_Phase 1]
This update describes an early-phase trial evaluating allogeneic CD19-CAR-NK cells for refractory myasthenia gravis, with the study currentl…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: EFG vs IVIG in TAMG [Phase 3]
Phase 3 trial planned to compare efgartigimod against intravenous immunoglobulin in thymoma-associated myasthenia gravis, with recruitment n…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Multi-Modal Monitoring of Disease Symptoms in Myasthenia Gravis
BioSensics is conducting a multi-modal monitoring study of symptoms in myasthenia gravis, with the trial currently NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry
ClinicalTrials.gov registry entry for the PPDTM CorEvitas Myasthenia Gravis Drug Safety and Effectiveness Registry. Sponsored by CorEvitas, …
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC) [Phase 2]
Phase 2 clinical trial evaluating DNTH103 in adults with generalized myasthenia gravis is active but not currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod [Phase 4]
Phase 4 clinical trial in elderly patients with generalized myasthenia gravis evaluating whether efgartigimod can enable corticosteroid-spar…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis [Phase 1]
A Phase 1 clinical trial is evaluating the safety and efficacy of a CD19-BCMA targeted CAR-T therapy for refractory generalized myasthenia g…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders
Development and validation of the FBIndex, a tool to assess falls risk in patients with various neuromuscular disorders.
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Capturing Key MG-symptoms Using Smartphone Recordings.
A clinical trial from Leiden University Medical Center uses smartphone recordings to capture key MG symptoms and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Interventions Against Fatigue in Patients With Myasthenia Gravis [NA]
A Leiden University Medical Center-led clinical trial is investigating interventions to reduce fatigue in patients with myasthenia gravis an…